NCT05296512
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05296512
Title Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Joyce Liu, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.